-
1
-
-
69249220247
-
Clinical impact of left ventricular hypertrophy and implications for regression
-
Artham S.M., Lavie C.J., Milani R.V., et al. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009, 52:153-167.
-
(2009)
Prog Cardiovasc Dis
, vol.52
, pp. 153-167
-
-
Artham, S.M.1
Lavie, C.J.2
Milani, R.V.3
-
2
-
-
84857519732
-
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling
-
Becker J.R., Robinson T.Y., Sachidanandan C., et al. In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. Cardiovasc Res 2012, 93:463-470.
-
(2012)
Cardiovasc Res
, vol.93
, pp. 463-470
-
-
Becker, J.R.1
Robinson, T.Y.2
Sachidanandan, C.3
-
3
-
-
71649084135
-
Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction
-
Buss S.J., Muenz S., Riffel J.H., et al. Beneficial effects of mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2009, 54:2435-2446.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 2435-2446
-
-
Buss, S.J.1
Muenz, S.2
Riffel, J.H.3
-
4
-
-
80052581224
-
Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish
-
Ding Y., Sun X., Huang W., et al. Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish. Circ Res 2011, 109:658-669.
-
(2011)
Circ Res
, vol.109
, pp. 658-669
-
-
Ding, Y.1
Sun, X.2
Huang, W.3
-
5
-
-
42749095390
-
Recycle or die: The role of autophagy in cardioprotection
-
Gustafsson A.B., Gottlieb R.A. Recycle or die: The role of autophagy in cardioprotection. J Mol Cell Cardiol 2008, 44:654-661.
-
(2008)
J Mol Cell Cardiol
, vol.44
, pp. 654-661
-
-
Gustafsson, A.B.1
Gottlieb, R.A.2
-
6
-
-
67650944993
-
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
-
Harrison D.E., Strong R., Sharp Z.D., et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 2009, 460:392-395.
-
(2009)
Nature
, vol.460
, pp. 392-395
-
-
Harrison, D.E.1
Strong, R.2
Sharp, Z.D.3
-
7
-
-
70449119936
-
Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy
-
Hassel D., Dahme T., Erdmann J., et al. Nexilin mutations destabilize cardiac Z-disks and lead to dilated cardiomyopathy. Nat Med 2009, 15:1281-1288.
-
(2009)
Nat Med
, vol.15
, pp. 1281-1288
-
-
Hassel, D.1
Dahme, T.2
Erdmann, J.3
-
8
-
-
4143135132
-
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial
-
Hausleiter J., Kastrati A., Mehilli J., et al. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: The Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation 2004, 110:790-795.
-
(2004)
Circulation
, vol.110
, pp. 790-795
-
-
Hausleiter, J.1
Kastrati, A.2
Mehilli, J.3
-
9
-
-
84863078561
-
Quantifying cardiac functions in embryonic and adult zebrafish
-
Hoage T., Ding Y., Xu X. Quantifying cardiac functions in embryonic and adult zebrafish. Methods Mol Biol 2012, 843:11-20.
-
(2012)
Methods Mol Biol
, vol.843
, pp. 11-20
-
-
Hoage, T.1
Ding, Y.2
Xu, X.3
-
10
-
-
33746530366
-
Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune U.S. Study Group
-
Kahan B.D. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: A randomised multicentre study. The Rapamune U.S. Study Group. Lancet 2000, 356:194-202.
-
(2000)
Lancet
, vol.356
, pp. 194-202
-
-
Kahan, B.D.1
-
11
-
-
20844461132
-
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial
-
Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial. Circulation 2004, 110:2694-2700.
-
(2004)
Circulation
, vol.110
, pp. 2694-2700
-
-
Keogh, A.1
Richardson, M.2
Ruygrok, P.3
-
12
-
-
33746090919
-
Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes
-
Khan S., Salloum F., Das A., et al. Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes. J Mol Cell Cardiol 2006, 41:256-264.
-
(2006)
J Mol Cell Cardiol
, vol.41
, pp. 256-264
-
-
Khan, S.1
Salloum, F.2
Das, A.3
-
13
-
-
34548407064
-
Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells
-
Knöll R., Postel R., Wang J., et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 2007, 116:515-525.
-
(2007)
Circulation
, vol.116
, pp. 515-525
-
-
Knöll, R.1
Postel, R.2
Wang, J.3
-
14
-
-
56449128027
-
Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients
-
Kushwaha S.S., Raichlin E., Sheinin Y., et al. Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J 2008, 29:2742-2750.
-
(2008)
Eur Heart J
, vol.29
, pp. 2742-2750
-
-
Kushwaha, S.S.1
Raichlin, E.2
Sheinin, Y.3
-
15
-
-
34347244963
-
Rapamycin prevents thyroid hormone-induced cardiac hypertrophy
-
Kuzman J.A., O'Connell T.D., Gerdes A.M. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy. Endocrinology 2007, 148:3477-3484.
-
(2007)
Endocrinology
, vol.148
, pp. 3477-3484
-
-
Kuzman, J.A.1
O'Connell, T.D.2
Gerdes, A.M.3
-
16
-
-
70350418625
-
MTOR signaling at a glance
-
Laplante M., Sabatini D.M. mTOR signaling at a glance. J Cell Sci 2009, 122:3589-3594.
-
(2009)
J Cell Sci
, vol.122
, pp. 3589-3594
-
-
Laplante, M.1
Sabatini, D.M.2
-
17
-
-
79952235006
-
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation
-
Marin T.M., Keith K., Davies B., et al. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest 2011, 121:1026-1043.
-
(2011)
J Clin Invest
, vol.121
, pp. 1026-1043
-
-
Marin, T.M.1
Keith, K.2
Davies, B.3
-
18
-
-
3042608187
-
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload
-
McMullen J.R., Sherwood M.C., Tarnavski O., et al. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload. Circulation 2004, 109:3050-3055.
-
(2004)
Circulation
, vol.109
, pp. 3050-3055
-
-
McMullen, J.R.1
Sherwood, M.C.2
Tarnavski, O.3
-
19
-
-
33745726634
-
In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation
-
Milan D.J., Jones I.L., Ellinor P.T., MacRae C.A. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol 2006, 291:H269-H273.
-
(2006)
Am J Physiol Heart Circ Physiol
, vol.291
-
-
Milan, D.J.1
Jones, I.L.2
Ellinor, P.T.3
MacRae, C.A.4
-
20
-
-
0036691215
-
Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients
-
Morrisett J.D., Abdel-Fattah G., Hoogeveen R., et al. Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res 2002, 43:1170-1180.
-
(2002)
J Lipid Res
, vol.43
, pp. 1170-1180
-
-
Morrisett, J.D.1
Abdel-Fattah, G.2
Hoogeveen, R.3
-
21
-
-
47349128927
-
Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: A 1-year nonrandomized controlled trial
-
Paoletti E., Amidone M., Cassottana P., et al. Effect of sirolimus on left ventricular hypertrophy in kidney transplant recipients: A 1-year nonrandomized controlled trial. Am J Kidney Dis 2008, 52:324-330.
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 324-330
-
-
Paoletti, E.1
Amidone, M.2
Cassottana, P.3
-
22
-
-
78649426029
-
Regression of left ventricular hypertrophy in kidney transplant recipients: The potential role for inhibition of mammalian target of rapamycin
-
Paoletti E., Cannella G. Regression of left ventricular hypertrophy in kidney transplant recipients: The potential role for inhibition of mammalian target of rapamycin. Transplant Proc 2010, 42:S41-S43.
-
(2010)
Transplant Proc
, vol.42
-
-
Paoletti, E.1
Cannella, G.2
-
23
-
-
84874552039
-
Effect of early conversion from CNI to sirolimus on outcomes in kidney transplant recipients with allograft dysfunction
-
Paoletti E., Ratto E., Bellino D., et al. Effect of early conversion from CNI to sirolimus on outcomes in kidney transplant recipients with allograft dysfunction. J Nephrol [Epub ahead of print] 2011.
-
(2011)
J Nephrol [Epub ahead of print]
-
-
Paoletti, E.1
Ratto, E.2
Bellino, D.3
-
24
-
-
37349072494
-
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation
-
Raichlin E., Bae J.H., Khalpey Z., et al. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation 2007, 116:2726-2733.
-
(2007)
Circulation
, vol.116
, pp. 2726-2733
-
-
Raichlin, E.1
Bae, J.H.2
Khalpey, Z.3
-
25
-
-
84855353573
-
Heart disease and stroke statistics-2012 update: A report from the American Heart Association
-
Roger V.L., Go A.S., Lloyd-Jones D.M., et al. Heart disease and stroke statistics-2012 update: A report from the American Heart Association. Circulation 2012, 125:e2-e220.
-
(2012)
Circulation
, vol.125
-
-
Roger, V.L.1
Go, A.S.2
Lloyd-Jones, D.M.3
-
26
-
-
58149396003
-
Autophagy in load-induced heart disease
-
Rothermel B.A., Hill J.A. Autophagy in load-induced heart disease. Circ Res 2008, 103:1363-1369.
-
(2008)
Circ Res
, vol.103
, pp. 1363-1369
-
-
Rothermel, B.A.1
Hill, J.A.2
-
27
-
-
0036578655
-
Cardiac troponin T is essential in sarcomere assembly and cardiac contractility
-
Sehnert A.J., Huq A., Weinstein B.M., et al. Cardiac troponin T is essential in sarcomere assembly and cardiac contractility. Nat Genet 2002, 31:106-110.
-
(2002)
Nat Genet
, vol.31
, pp. 106-110
-
-
Sehnert, A.J.1
Huq, A.2
Weinstein, B.M.3
-
28
-
-
46649112177
-
Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function
-
Shen W.H., Chen Z., Shi S., et al. Cardiac restricted overexpression of kinase-dead mammalian target of rapamycin (mTOR) mutant impairs the mTOR-mediated signaling and cardiac function. J Biol Chem 2008, 283:13842-13849.
-
(2008)
J Biol Chem
, vol.283
, pp. 13842-13849
-
-
Shen, W.H.1
Chen, Z.2
Shi, S.3
-
29
-
-
79953033875
-
Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice
-
Shende P., Plaisance I., Morandi C., et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 2011, 123:1073-1082.
-
(2011)
Circulation
, vol.123
, pp. 1073-1082
-
-
Shende, P.1
Plaisance, I.2
Morandi, C.3
-
30
-
-
0037382861
-
Rapamycin attenuates load-induced cardiac hypertrophy in mice
-
Shioi T., McMullen J.R., Tarnavski O., et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 2003, 107:1664-1670.
-
(2003)
Circulation
, vol.107
, pp. 1664-1670
-
-
Shioi, T.1
McMullen, J.R.2
Tarnavski, O.3
-
31
-
-
78649668307
-
MTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy
-
Song X., Kusakari Y., Xiao C.Y., et al. mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy. Am J Physiol Cell Physiol 2010, 299:C1256-C1266.
-
(2010)
Am J Physiol Cell Physiol
, vol.299
-
-
Song, X.1
Kusakari, Y.2
Xiao, C.Y.3
-
32
-
-
12644276397
-
Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo
-
Stainier D.Y., Fouquet B., Chen J.N., et al. Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development 1996, 123:285-292.
-
(1996)
Development
, vol.123
, pp. 285-292
-
-
Stainier, D.Y.1
Fouquet, B.2
Chen, J.N.3
-
33
-
-
37049031465
-
In vivo cardiac imaging of adult zebrafish using high frequency ultrasound (45-75 MHz)
-
Sun L., Lien C.L., Xu X., Shung K.K. In vivo cardiac imaging of adult zebrafish using high frequency ultrasound (45-75 MHz). Ultrasound Med Biol 2008, 34:31-39.
-
(2008)
Ultrasound Med Biol
, vol.34
, pp. 31-39
-
-
Sun, L.1
Lien, C.L.2
Xu, X.3
Shung, K.K.4
-
34
-
-
68949096731
-
Cardiac hypertrophy involves both myocyte hypertrophy and hyperplasia in anemic zebrafish
-
Sun X., Hoage T., Bai P., et al. Cardiac hypertrophy involves both myocyte hypertrophy and hyperplasia in anemic zebrafish. PLoS ONE 2009, 4:e6596.
-
(2009)
PLoS ONE
, vol.4
-
-
Sun, X.1
Hoage, T.2
Bai, P.3
-
35
-
-
34147155267
-
Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient
-
Turska-Kmieć A., Jankowska I., Pawłowska J., et al. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient. Pediatr Transplant 2007, 11:319-323.
-
(2007)
Pediatr Transplant
, vol.11
, pp. 319-323
-
-
Turska-Kmieć, A.1
Jankowska, I.2
Pawłowska, J.3
-
36
-
-
0036478894
-
Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin
-
Xu X., Meiler S.E., Zhong T.P., et al. Cardiomyopathy in zebrafish due to mutation in an alternatively spliced exon of titin. Nat Genet 2002, 30:205-209.
-
(2002)
Nat Genet
, vol.30
, pp. 205-209
-
-
Xu, X.1
Meiler, S.E.2
Zhong, T.P.3
-
37
-
-
77955290360
-
MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice
-
Zhang D., Contu R., Latronico M.V., et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest 2010, 120:2805-2816.
-
(2010)
J Clin Invest
, vol.120
, pp. 2805-2816
-
-
Zhang, D.1
Contu, R.2
Latronico, M.V.3
-
38
-
-
59049091824
-
Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway
-
Zhu W., Soonpaa M.H., Chen H., et al. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway. Circulation 2009, 119:99-106.
-
(2009)
Circulation
, vol.119
, pp. 99-106
-
-
Zhu, W.1
Soonpaa, M.H.2
Chen, H.3
-
39
-
-
78650510609
-
MTOR: From growth signal integration to cancer, diabetes and ageing
-
Zoncu R., Efeyan A., Sabatini D.M. mTOR: From growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011, 12:21-35.
-
(2011)
Nat Rev Mol Cell Biol
, vol.12
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
40
-
-
38949125143
-
Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation
-
Zuckermann A., Manito N., Epailly E., et al. Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation. J Heart Lung Transplant 2008, 27:141-149.
-
(2008)
J Heart Lung Transplant
, vol.27
, pp. 141-149
-
-
Zuckermann, A.1
Manito, N.2
Epailly, E.3
|